Longevity & AgingResveratrol Fights Obesity Via Gut Microbe Metabolite That Activates SIRT1
Researchers discovered that resveratrol's anti-obesity effects depend heavily on gut microbiota. When mice on a high-fat diet received resveratrol, their gut bacteria produced a metabolite called 4-hydroxyphenylacetic acid (4-HPA). This compound alone was sufficient to reduce obesity, improve glucose tolerance, and activate SIRT1 signaling — a key longevity and metabolic pathway. Antibiotic depletion of gut microbiota abolished resveratrol's benefits, while fecal transplants from resveratrol-treated donors reproduced them. 4-HPA also promoted 'browning' of white adipose tissue, enhancing fat burning. Blocking SIRT1 with the inhibitor EX527 partially reversed 4-HPA's benefits, confirming SIRT1 as a central mediator. These findings reframe resveratrol as a prebiotic-like compound whose benefits are largely microbially mediated.
